12-51769111-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_001330260.2(SCN8A):c.3148G>A(p.Gly1050Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000108 in 1,613,404 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 1 hom. )
Consequence
SCN8A
NM_001330260.2 missense
NM_001330260.2 missense
Scores
2
6
11
Clinical Significance
Conservation
PhyloP100: 4.37
Genes affected
SCN8A (HGNC:10596): (sodium voltage-gated channel alpha subunit 8) This gene encodes a member of the sodium channel alpha subunit gene family. The encoded protein forms the ion pore region of the voltage-gated sodium channel. This protein is essential for the rapid membrane depolarization that occurs during the formation of the action potential in excitable neurons. Mutations in this gene are associated with cognitive disability, pancerebellar atrophy and ataxia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN8A. . Gene score misZ 0.78755 (greater than the threshold 3.09). Trascript score misZ 10.436 (greater than threshold 3.09). GenCC has associacion of gene with myoclonus, familial, 2, infantile convulsions and choreoathetosis, cognitive impairment with or without cerebellar ataxia, undetermined early-onset epileptic encephalopathy, complex neurodevelopmental disorder, developmental and epileptic encephalopathy, 13, benign familial infantile epilepsy, seizures, benign familial infantile, 5.
BP4
Computational evidence support a benign effect (MetaRNN=0.18225342).
BS2
High AC in GnomAd4 at 26 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN8A | NM_001330260.2 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/27 | ENST00000627620.5 | NP_001317189.1 | |
SCN8A | NM_014191.4 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/27 | ENST00000354534.11 | NP_055006.1 | |
SCN8A | NM_001177984.3 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/26 | NP_001171455.1 | ||
SCN8A | NM_001369788.1 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/26 | NP_001356717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN8A | ENST00000354534.11 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
SCN8A | ENST00000627620.5 | c.3148G>A | p.Gly1050Ser | missense_variant | 17/27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
SCN8A | ENST00000599343.5 | c.3181G>A | p.Gly1061Ser | missense_variant | 16/26 | 5 | ENSP00000476447.3 | |||
SCN8A | ENST00000355133.7 | c.3148G>A | p.Gly1050Ser | missense_variant | 16/25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152168Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
26
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000808 AC: 20AN: 247622Hom.: 0 AF XY: 0.0000670 AC XY: 9AN XY: 134352
GnomAD3 exomes
AF:
AC:
20
AN:
247622
Hom.:
AF XY:
AC XY:
9
AN XY:
134352
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461118Hom.: 1 Cov.: 31 AF XY: 0.0000853 AC XY: 62AN XY: 726786
GnomAD4 exome
AF:
AC:
148
AN:
1461118
Hom.:
Cov.:
31
AF XY:
AC XY:
62
AN XY:
726786
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 26AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74462
GnomAD4 genome
AF:
AC:
26
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
13
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
10
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | SCN8A: PP2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 21, 2019 | This variant is associated with the following publications: (PMID: 27875746, 25666757) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 12, 2017 | - - |
Seizures, benign familial infantile, 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Mar 05, 2021 | The inherited heterozygous c.3148G>A (p.Gly1050Ser) variant identified in the SCN8A gene has been reported in the literature as de novo in a patient affected with hemiplegic cerebral palsy and intellectual disability [2]. The variant has been reported in ClinVar database with conflicting interpretations of pathogenicity [benign (1), likely benign (1), uncertain significance (2). Variation ID:207142]. The variant has 0.0001709 allele frequency in the gnomAD(v3) database (26 out of 152168 heterozygous alleles, no homozygotes) suggesting it is not a common benign variant in the populations represented in that database. The affected residue is evolutionarily conserved and is predicted deleterious by in silico predictiontools [CADD score= 22.5, REVEL score = 0.828]. Based on the available evidence, the inherited heterozygous c.3148G>A (p.Gly1050Ser) variant identified in the SCN8A gene is reported as a variant of uncertainsignificance. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 08, 2024 | - - |
SCN8A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 04, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;.;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L;L;.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;.;.
REVEL
Pathogenic
Sift
Benign
T;T;T;.;.
Sift4G
Benign
T;T;T;T;T
Polyphen
P;.;.;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at